Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001451612-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
22,212
Total Value
$944,709.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 4,159 | $14.18 | $58,974.62 | 4,159 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 14, 2026 | Sale | 4,159 | $89.97 | $374,185.23 | 0 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 15, 2026 | Exercise/Conversion | 2,200 | $14.18 | $31,196.00 | 2,200 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 15, 2026 | Sale | 2,200 | $89.95 | $197,890.00 | 0 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 15, 2026 | Sale | 2,750 | $90.10 | $247,775.00 | 3,899,917 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Apr 15, 2026 | Sale | 385 | $90.10 | $34,688.50 | 674,956 | Indirect | See footnote | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 4,159 | $0.00 | $0.00 | 7,841 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 15, 2026 | Exercise/Conversion | 2,200 | $0.00 | $0.00 | 5,641 | Direct | โ | View Details |